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Prolonged Normothermic Ex Vivo Kidney 
Perfusion Is Superior to Cold Nonoxygenated 
and Oxygenated Machine Perfusion for the 
Preservation of DCD Porcine Kidney Grafts
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Kidney Transplantation
Background. The increased usage of marginal grafts has triggered interest in perfused kidney preservation to minimize graft 
injury. We used a donation after circulatory death (DCD) porcine kidney autotransplantation model to compare 3 of the most 
frequently used ex vivo kidney perfusion techniques: nonoxygenated hypothermic machine perfusion (non-oxHMP), oxygenated 
hypothermic machine perfusion (oxHMP), and normothermic ex vivo kidney perfusion (NEVKP). Methods. Following 30 min 
of warm ischemia, grafts were retrieved and preserved with either 16 h of non-oxHMP, oxHMP, or NEVKP (n = 5 per group). After 
contralateral nephrectomy, grafts were autotransplanted and animals were followed for 8 d. Kidney function and injury markers 
were compared between groups. Results. NEVKP demonstrated a significant reduction in preservation injury compared 
with either cold preservation method. Grafts preserved by NEVKP showed superior function with lower peak serum creati-
nine (NEVKP versus non-oxHMP versus oxHMP: 3.66 ± 1.33 mg/dL, 8.82 ± 3.17 mg/dL, and 9.02 ± 5.5 mg/dL) and more rapid 
recovery. The NEVKP group demonstrated significantly increased creatinine clearance on postoperative day 3 compared with 
the cold perfused groups. Tubular injury scores on postoperative day 8 were similar in all groups. Conclusions. Addition of 
oxygen during HMP did not reduce preservation injury of DCD kidney grafts. Grafts preserved with prolonged NEVKP demon-
strated superior initial graft function compared with grafts preserved with non-oxHMP or oxHMP in a model of pig DCD kidney 
transplantation.
(Transplantation Direct 2021;7: e751; doi: 10.1097/TXD.0000000000001218. Published online 7 September, 2021.)
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INTRODUCTION
Kidney transplantation improves survival and quality of 
life of patients with end-stage renal disease and has there-
fore become the preferred treatment for patients with end-
stage renal disease.1,2 Because of the severe organ shortage, 
marginal grafts have been increasingly used for transplanta-
tion.3 Static cold storage (SCS) results in excellent outcomes 
for standard criteria grafts; however, grafts from extended 
criteria donors and donation after circulatory death (DCD) 
tolerate SCS only poorly, with a higher rate of postoperative 
delayed graft function, primary nonfunction and graft loss.3-5 
To reduce preservation injury and to assess graft functionality 
and viability before transplantation, the research community 
has explored several ex vivo machine perfusion techniques.
Hypothermic machine perfusion (HMP) without oxygen 
has been extensively used in a clinical setting and studies report 
decreased delayed graft function and improved 1- and 3-y 
graft survival in grafts preserved with HMP compared with 
SCS.6-8 Oxygenation during HMP has also been explored, and 
animal studies show conflicting results regarding the benefits 
of this approach.9-11 However, a recent clinical trial found that 
oxygenated hypothermic machine perfusion (oxHMP) results 
in increased 1-y graft survival compared with non-oxHMP.12
To reduce preservation injury and improve the outcome 
of marginal grafts, novel technologies, such as normother-
mic ex vivo kidney perfusion (NEVKP), have been increas-
ingly explored in the past years. Preclinical results suggest 
that NEVKP is superior to non-oxHMP and SCS.13-15 Clinical 
studies investigating the safety and benefits of NEVKP are 
scarce, but first results are promising.16,17
Studies comparing the postoperative function of DCD 
grafts stored with NEVKP and oxHMP are lacking. Also, pre-
vious studies have shown contradicting results regarding the 
effects of adding oxygenation during cold perfusion.9,18 This 
study is the first to directly compare nonoxygenated and oxy-
genated HMP with NEVKP in a standardized porcine DCD 
kidney autotransplantation model. Kidney injury and graft 
function was assessed in vivo over 8 d follow-up.
MATERIALS AND METHODS
Animals and Study Groups
The study was approved by the Animal Care Committee of 
the University Health Network Research Institute, Ontario, 
Canada. Twelve-wk-old male Yorkshire pigs (~30 kg) were 
utilized.
The pigs were randomly assigned to 1 of the 3 groups. 
After 30 min of warm ischemia (WI), grafts were retrieved 
and preserved either by nonoxygenated HMP (non-oxHMP 
group), oxygenated HMP (oxHMP group), or NEVKP 
(NEVKP group) (Figure 1). After contralateral kidney resec-
tion and autotransplantation of the preserved grafts, animals 
were followed for 8 d. During the follow-up period, blood 
was collected daily and fluids and antibiotics were adminis-
tered twice daily as previously reported.19 At the end of the 
8 d, animals were euthanized under anesthesia. All animals 
received humane care and all procedures were performed in 
accordance with the “Principles of Laboratory Animal Care” 
and the “Guide for the Care of Laboratory Animals” pub-
lished by the National Society for Medical Research and by 
the National Institutes of Health, respectively. Some of the 
data of the NEVKP and non-oxHMP groups includes histori-
cal controls.13
Surgical Protocol
The anesthetic and surgical procedures were performed as 
previously described by our group.19 After anesthesia induction 
and intubation, general anesthesia was maintained by admin-
istration of inhaled isoflurane. Next, a central venous catheter 
was placed into the internal jugular vein for blood collection 
and administration of fluids and medications. Following mid-
line incision and dissection of the right kidney and its vessels, 
the renal artery and vein were clamped with vascular clamps for 
30 min to induce WI, mimicking DCD conditions. Subsequently, 
grafts were retrieved, the renal vessels were cannulated and the 
grafts were flushed with 300 mL histidine-trytophan-ketoglut-
arate (HTK), containing 10 000 IU/L heparin. After flush, the 
grafts were connected to the cold or warm perfusion device for 
the preservation period. The abdomen was closed, and animals 
were recovered from surgery. Toward the end of the preserva-
tion time, animals were reanesthetized. Following reintubation, 
anesthesia was maintained by continuous intravenous propofol 
administration and inhaled isofluorane. The midline laparot-
omy was reopened, and the left kidney was resected. The stored 
kidney was then flushed with 300 mL heparinized HTK, and 
the renal anastomoses were sewed (renal vein end-to-side to 
vena cava, renal artery end-to-side to aorta, and donor ureter 
side-to-side to recipient ureter). The abdomen was closed, and 
the animals were recovered and followed for 8 d.
Nonoxygenated Hypothermic Machine Perfusion
HMP without oxygen was performed using a LifePort 1.0 
device (Organ Recovery Systems, Itaska, IL). The circuit was 
prepared sterile according to the manufacturer instructions and 
primed with 1 L of Belzer’s Machine Perfusion Solution (Bridge 
to Life Ltd, Columbia, SC). After cannulation of the renal 
FIGURE 1. Study groups: Pigs were randomly assigned to 1 of the 3 groups (n = 5 in each group). After 30 min of warm ischemia, kidneys 
were retrieved and preserved with either 16 h of nonoxygenated HMP (non-oxHMP group), oxygenated HMP (oxHMP group), or normothermic 
ex vivo kidney perfusion (NEVKP group). Following perfusion and after contralateral nephrectomy, grafts were autotransplanted and animals 
were followed for 8 d. HMP, hypothermic machine perfusion; NEVKP, normothermic ex vivo kidney perfusion; non-oxHMP, nonoxygenated 
hypothermic machine perfusion; oxHMP, oxygenated hypothermic ex vivo machine perfusion.
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artery, the graft was flushed, placed into the cassette, and per-
fused with a mean arterial pressure of 30 mm Hg. The tempera-
ture was maintained at 3–6°C throughout the preservation. No 
oxygen was provided during the perfusion, and because of the 
closed circuit, Po
2
 levels decreased during perfusion from circa 
250 mm Hg at baseline to 50 mm Hg at the end of perfusion.
Normothermic Ex Vivo Kidney Perfusion
Our NEVKP system has been previously described.20 The 
S3 heart-lung machine and neonatal cardiopulmonary bypass 
equipment consists of a centrifugal pump, an oxygenator, a 
venous reservoir, an arterial bubble filter, and PVC tubing 
(Sorin Group Inc., Markham, Canada). Additionally, a heat 
exchanger and a customized double-walled heated organ cham-
ber were built into the system. Perfusion circuit parameters 
(temperature, arterial and venous pressure, and arterial flow) 
were continuously recorded. The perfusate solution is made 
of Ringer’s lactate, STEEN Solution (XVIVO Perfusion AB, 
Goteborg, Sweden), washed leukocyte-filtered erythrocytes, 
double reverse osmosis water, sodium bicarbonate, calcium 
gluconate, and heparin. Oxygen/carbon dioxide gas (95%/5%; 
2 L/min) was provided continuously during perfusion, resulting 
in Po
2
 levels around 650 mm Hg during the entire preservation 
time. Also, verapamil and an infusion of amino acids, glucose, 
and insulin were administered continuously during perfusion.21 
Arterial pressure was initially set at 75 mm Hg and maintained 
at 65 mm Hg by adjusting the rate of the centrifugal pump.
Oxygenated Hypothermic Machine Perfusion
Our pressure controlled, nonpulsatile NEVKP system, 
that was previously described20 and briefly presented above, 
was modified to perform HMP. Instead of a heat exchanger, 
a heater-cooler device was attached to cool down the sys-
tem. The system was primed with 1.5 L of Belzer’s Machine 
Perfusion Solution. The kidney was placed in a chamber that 
was surrounded by ice. The temperature was maintained 
at 3–6°C throughout the perfusion. Oxygen (75 mL/min) 
was administered continuously during the perfusion using a 
membrane oxygenator, maintaining the Po
2
 levels at around 
650 mm Hg for the whole preservation time. Arterial pressure 
was set and maintained at 30 mm Hg, just as in the LifePort 
system. To mimic the conditions in the LifePort 1.0 device, 
the vein was not cannulated and the venous perfusate gath-
ered around the kidney. While the kidney was continuously 
submerged in solution, a roller pump also recirculated this 
reservoir fluid to the perfusion circuit.
During all perfusions, perfusate samples were collected 
regularly and stored at –80°C for further investigation. 
Additionally, during NEVKP urine samples were collected 
regularly. At the end of each preservation method, the kidney 
was removed from the device, reflushed with 300 mL heparin-
ized HTK, and stored on ice until transplantation.
Sample Collection
Blood gas analyses of the perfusate were performed hourly 
during graft perfusion. Additionally, blood gas analyses of 
the subject were taken before retrieval, before transplanta-
tion, and every day during postoperative care. Samples were 
also analyzed using a point-of-care comprehensive meta-
bolic blood chemistry analyzer (Piccolo Xpress, Union City, 
Canada) and part of each sample was stored at –80°C for 
later analysis.
Using a customized metabolic cage, 24-h urine collection 
was done before transplantation and at postoperative day 
(POD) 2–3. During the 24-h urine collection in the metabolic 
cage, animals had to be housed separately, to allow individual 
urine collection. For creatinine clearance and lactate dehydro-
genase (LDH) measurements, 24-h urine collection as well as 
serum samples were sent to the Toronto General Hospital Core 
Laboratory for analysis with the Abbott Architect Chemistry 
Analyzer using the manufacturer’s reagents. For measurement 
of urinary neutrophil gelatinase-associated lipocalin (NGAL), 
porcine NGAL enzyme linked immunosorbent assays kit was 
used according to manufacturer’s instructions.
Histology
At sacrifice on POD8, wedge biopsies were taken from the 
renal graft. All samples were placed in 10% neutral buffered 
formalin and transferred to 70% alcohol after 36 to 48 h. 
Following paraffin-embedding and sectioning (3-μm), peri-
odic acid-Schiff (PAS) stained sections were used to score 
global tubular injury on a semiquantitative scale of 0 to 3 
(0-no changes, 1-mild, 2-moderate, 3-severe changes) by a 
renal pathologist blinded to the experimental groups. The 
tubular injury score was based on the degree of brush bor-
der loss, tubular dilatation, epithelial vacuolation, thinning 
and sloughing, and luminal debris/casts. The changes were 
assessed over 20 high power fields and averaged.
High-sensitivity Flow Cytometry Analyses of 
Apoptotic Exosome-like Vesicles
All the analyses were performed on a BD Canto II Special 
Order Research Product (BD Biosciences) equipped with a 
small particle option, as described previously.22,23 Perfusates 
(10 µL) were labeled in a total reaction volume of 50 μL at 
32°C for 60 min with LWA 300 probe (300 nM). Cell tracker 
deep red (1 µM, ThermoFicher Scientific) was added for 30 min 
at 32°C and then 1 µL of Annexin V-BV421 (BD Biosciences) 
was added for 20 min at room temperature. Then, the sample 
was diluted by adding 250 µL of labeling buffer prior analysis 
by high-sensitivity flow cytometry.
Statistical Analysis
All statistical analyses were performed with RStudio soft-
ware (version 1.1.463). Descriptive statistics were calculated 
(mean ± SD) and tests were conducted to compare variables 
between the study groups and subgroups. For continuous 
variables, when a normal distribution of data was identified, 
ANOVA test was used for comparing groups; in the case of 
a non-normal distribution, Kruskall-Wallis test was used for 
analysis. When significance was reached, t-tests, respectively, 
Wilcoxon tests were performed to determine which 2 groups 
were significantly different. A paired t-test was used to test 
significance of differences in normally distributed continuous 
parameters over time within the same group. Significance was 
defined as P < 0.05.
RESULTS
Animal Characteristics and Survival
Average animal weight was similar between groups 
(NEVKP: 30.2 ± 2.4 kg, non-oxHMP: 30.8 ± 1.2 kg, oxHMP: 
29.1 ± 1 kg, P = 0.47). Pigs were randomly assigned to 1 of the 
3 groups, and no animals were replaced in any of the groups. 
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All animals survived until day 8 in each group except 1 in 
the non-oxHMP group. This pig was euthanized on POD7 
because of sudden respiratory decompensation of unclear eti-
ology. Despite this, its renal function was comparable to other 
animals in this group, and the animal was not excluded from 
the analysis.
Perfusion Parameters
Hypothermic Machine Perfusion With and Without 
Oxygen
Kidney grafts that were subjected to non-oxHMP demon-
strated improvement in flow rates and resistance index dur-
ing preservation, with a significant difference between values 
at baseline (values measured at 5 min after the perfusion was 
started) compared with the end of the perfusion (P < 0.001). 
Similar perfusion dynamics were observed in kidney grafts 
that were subjected to oxHMP: flow rates improved over the 
course of perfusion (P = 0.5), and the resistance index was sig-
nificantly lower at the end of the perfusion compared with 
baseline (P = 0.02) (Figure 2A and B). A significant increase 
in perfusate lactate concentration (baseline: 0.28 ± 0.07, 15 h: 
0.88 ± 0.13 mmol/l, P = 0.0033) developed during non-oxHMP, 
along with a minimal decrease in perfusate glucose concentra-
tion (baseline: 10.2 ± 0.4, 15 h: 9.3 ± 0.5 mmol/L, P = 0.053). 
During oxHMP, both lactate concentration (1 h: 0.28 ± 0.19, 
15 h: 0.53 ± 0.34 mmol/L, P > 0.05) and glucose concentra-
tion (1 h: 9.72 ± 0.21, 15 h: 10.24 ± 0.25 mmol/L, P = 0.008) 
increased (Figure 3A and C). During both non-oxHMP and 
oxHMP, injury marker LDH increased during perfusion, but 
overall LDH values remained low (non-oxHMP: 1 h: 10 ± 4.6, 
15 h: 35.4 ± 10.6 U/L, P = 0.003; oxHMP: 1 h: 8.6 ± 5, 15 h: 
58.8 ± 27.6 U/L, P = 0.01) (Figure 4A).
Normothermic Ex Vivo Kidney Perfusion
Renal blood flow progressively increased during the per-
fusion (P < 0.01), whereas the intrarenal vascular resistance 
significantly decreased (P = 0.004) (Figure  2A and B). The 
acid-base parameters (pH–Figure  3D, bicarbonate, base 
excess) and electrolyte concentrations (serum sodium, potas-
sium, calcium, and chloride) were stable within physiologic 
range during the entire time of NEVKP. Lactate significantly 
decreased throughout the perfusion (baseline: 9.6 ± 0.6 ver-
sus 16 h: 1.6 ± 0.6 mmol/L, P < 0.001) (Figure 3B), whereas 
glucose significantly increased (baseline: 5.2 ± 0.9 versus 16 
h: 9.8 ± 0.3 mmol/L, P = 0.001) (Figure 3C). LDH, a marker 
of injury, showed an increase during perfusion, but overall 
values remained low (1 h: 20 ± 5.5 U/L, 15 h: 57 ± 27.7 U/L, 
P = 0.03) (Figure 4A). All kidneys produced urine during the 
perfusion. Cumulative urine production was 161 ± 103 mL 
during NEVKP.
Posttransplant Graft Function and Injury
Kidneys preserved by NEVKP demonstrated improved 
graft function with lower mean peak serum creatinine (SCr) 
and faster recovery that occurred earlier compared with non-
oxHMP and oxHMP (Figure  5A). The differences between 
daily serum creatinine levels reached significance between 
NEVKP and both non-oxHMP and oxHMP on POD1, 2, 
and 3 (all P < 0.05) and, in addition, between NEVKP and 
oxHMP on POD7 and 8 (P < 0.05) (Figure  5A). There was 
no difference in posttransplant graft function between the 2 
cold perfused groups. The area under the curve analysis of the 
SCr from POD1 to POD8 did not show any significant differ-
ence between the 3 groups (all P > 0.05). Blood urea nitrogen 
showed a similar trend to SCr, with the NEVKP group having 
lower levels compared with the other 2 groups.
All 3 groups showed similar creatinine clearance at base-
line (Figure 5B). In contrast, creatinine clearance on POD3 
was significantly increased in the warm perfused group com-
pared with the cold perfused groups (NEVKP: 63.6 ± 19.0 
versus non-oxHMP: 11.4 ± 10.1 and oxHMP: 10.1 ± 12.5, 
P = 0.001).
Postoperative urine NGAL was measured in a random sam-
ple from the 24-h urine collection. Urine NGAL measurements 
were normalized to urinary creatinine concentration. Grafts 
perfused with NEVKP showed significantly lower normalized 
NGAL values compared with the other 2 groups on POD3 
(NEVKP: 0.5 ± 0.2 versus non-oxHMP: 1.8 ± 0.8 and oxHMP: 
1.4 ± 0.3, P = 0.01) (Figure  6). There were no differences 
between the 2 groups that received cold perfusion on POD3.
Injury marker LDH decreased daily in all groups (Figure 4B). 
No significant differences were present on POD1, but on 
POD3 LDH was slightly lower in the oxHMP group compared 
with the non-oxHMP and NEVKP groups (P = 0.01).
Renal tissue samples were collected for histology and PAS 
stained slides were assessed by a blinded renal pathologist. 
Tubular injury scores were similar in all groups (P = 0.17) 
(Figure 7A and B).
As marker of endothelial injury, the levels of apoptotic exo-
some (ApoExo)-like vesicles were measured in the perfusate 
at 1 h of perfusion. The NEVKP group had lower levels of 
ApoExo compared with the cold perfused groups. However, 
significance between groups was reached only between the 
NEVKP and the oxHMP group (P = 0.02) (Figure 8).
DISCUSSION
This study is the first to compare, head-to-head, the out-
comes of the 3 clinically utilized ex vivo machine perfusion 
techniques used for prolonged DCD graft preservation. Here, 
we demonstrated that grafts preserved with NEVKP from 
procurement until transplantation show initial superior graft 
function compared with non-oxHMP and oxHMP preserved 
grafts. No difference was found between the 2 cold preserva-
tion methods.
Grafts preserved with NEVKP demonstrated improved 
preservation injury, lower peak SCr, improved creatinine 
clearance at POD3, and lower urine NGAL as marker of kid-
ney injury at POD3. Histology at the end of follow-up on 
POD8 showed no differences between groups regarding tubu-
lar injury and inflammation. This is in alignment with kidney 
function, which had nearly normalized in all groups by POD8. 
Animals were observed for 8 d to assess the time that the graft 
needed to return to a normal function. Because the animals 
cannot be biopsied during the follow-up period, histology 
could only be procured at the time of sacrifice. Histological 
difference would be expected at earlier timepoints. No dif-
ferences were found between the cold perfused group with 
oxygen and without oxygen in terms of graft function and 
injury. Differences in lactate values over the course of perfu-
sion between the cold perfused groups and the NEVKP group 
are likely because of the differences in perfusate. Of note, the 
perfusate of the NEVKP group contained Ringers Lactate, 
whereas the cold perfusion perfusates did not.
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FIGURE 2. Pump parameters. All values are presented as mean ± SD (n = 5 in each group). (A) Renal arterial flow. (B) Intrarenal vascular 
resistance. In all 3 groups, there was an improvement in the renal arterial flow (P < 0.01 for the non-oxHMP and NEVKP groups, P = 0.5 for 
the oxHMP) and a significant decrease in the intrarenal vascular resistance (all P < 0.05) over the 16 h of perfusion. NEVKP, normothermic 
ex vivo kidney perfusion; non-oxHMP, nonoxygenated hypothermic machine perfusion; oxHMP, oxygenated hypothermic ex vivo machine 
perfusion.
FIGURE 3. Pump metabolites. All values are presented as mean ± SD (n = 5 in each group). (A) Perfusate lactate during HMP with and without 
oxygen. Lactate increased both during non-oxHMP (P = 0.0033) and oxHMP (P > 0.05) over the course of perfusion. (B) Perfusate lactate during 
NEVKP. Lactate significantly decreased during NEVKP over the 16 h of perfusion (P < 0.001). (C) Perfusate glucose during HMP with and without 
oxygen and NEVKP. Glucose concentration slightly decreased during non-oxHMP (P = 0.053) and significantly increased during oxHMP and 
NEVKP (both P < 0.01). (D) Perfusate pH during NEVKP. Perfusate pH was stable and within physiologic range during the NEVKP perfusion. 
NEVKP, normothermic ex vivo kidney perfusion; non-oxHMP, nonoxygenated hypothermic machine perfusion; oxHMP, oxygenated hypothermic 
ex vivo machine perfusion.
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To date, the effects of oxygenation during HMP on pres-
ervation injury and kidney function have been contradict-
ing. Venema et al found that the addition of oxygen during 
HMP did not improve kidney function compared with non-
oxHMP.18 In this study, kidneys subjected to 30 min of WI 
were preserved for 24 h with SCS, HMP with 21% oxygen 
or HMP with 100% oxygen and then reperfused ex vivo for 
4 h to mimic transplantation. HMP was superior to SCS; 
however, the oxygen levels did not influence graft function. 
The authors reported reduced oxidative stress and energy 
status in grafts perfused with 100% oxygen. However, using 
a reperfusion model instead of a transplant model has its 
limitations. Duration of follow-up is only limited to a few 
hours and important cellular components and mediators 
of injury and regeneration are not present in the perfusate. 
In addition, urine production, as an endpoint of function, 
requires hormonal support, which is absent during ex vivo 
reperfusion.
Our results are in contrast with a study presented by Darius 
et al, who found that oxHMP is superior to non-oxHMP.9 
After 30 min of WI and either 22 h of HMP with or without 
oxygen or 20 h of non-oxHMP followed by 2 h of warm per-
fusion, grafts were transplanted, and animals were followed 
for 13 d. Peak SCr was lowest in the oxHMP group, though 
without reaching significance compared with the other 2 
groups. The area under the curve analysis of SCr showed a sig-
nificantly lower creatinine for the oxHMP group compared to 
the non-oxHMP group, and the HMP+NEVKP group. When 
normalizing the SCr to pig body weight, there was a significant 
difference on POD2 and POD3 between the oxygenated and 
nonoxygenated HMP groups. The authors argued that this 
demonstrates the superiority of oxHMP over non-oxHMP and 
HMP+NEVKP. The variation in cold ischemia times between 
the studies might contribute to the different findings.24
A recent clinical trial investigated the benefits of continu-
ous oxygenated versus nonoxygenated cold perfusion in DCD 
FIGURE 5. Posttransplant graft function. All values are presented as mean ± SD (n = 5 in each group). (A) Serum creatinine of transplanted 
animals during the 8 d follow-up. Overall, there was a significantly lower serum creatinine in the NEVKP group compared with the other 2 
groups (all P < 0.05). There were no significant differences between the 2 cold perfused groups. (B) Creatinine clearance at baseline and POD3. 
Creatinine clearance on POD3 was significantly higher in the NEVKP group vs the other 2 groups (P = 0.001). No differences were found between 
the 2 cold perfused graousp. * indicates significance between NEVKP and non-oxHMP; ¥ indicates significance between NEVKP and oxHMP. 
non-oxHMP. NEVKP, normothermic ex vivo kidney perfusion; non-oxHMP, nonoxygenated hypothermic machine perfusion; oxHMP, oxygenated 
hypothermic ex vivo machine perfusion; POD, postoperative day.
FIGURE 4. Injury marker LDH. All values are presented as mean ± SD (n = 5 in each group). (A) Perfusate LDH. Perfusate LDH increased during 
perfusion in all 3 groups; however, values remained low (all P < 0.05). (B) Serum LDH posttransplantation. Serum LDH decreased daily in all 
3 groups; on POD3, LDH levels were lower in the oxHMP group compared with the other 2 groups (P = 0.01). LDH, lactate dehydrogenase; 
NEVKP, normothermic ex vivo kidney perfusion; non-oxHMP, nonoxygenated hypothermic machine perfusion; oxHMP, oxygenated hypothermic 
ex vivo machine perfusion; POD, postoperative day.
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grafts.12 This European trial found no differences in the esti-
mated glomerular filtration rate at 1-y but a decreased graft 
loss in the oxygenated group. Also, the authors report less 
acute rejection episodes in the oxygenated group. Another 
clinical trial investigated the benefits of end-ischemic oxygen-
ated HMP after SCS in extended criteria brain dead donors.25 
The group that received short-term oxHMP before transplan-
tation showed no improvement in graft function and survival 
compared with the group that received SCS alone. Our find-
ings are in accordance with these studies, highlighting that 
oxygenation during HMP did not result in superior graft 
function compared with HMP without oxygen. The benefits 
of oxygenation during HMP remain inconclusive. However, 
our study indicates that the mere addition of oxygen during 
HMP is not enough to improve graft function after transplan-
tation in moderately damaged kidney grafts. Further stud-
ies need to determine whether oxygenated HMP could have 
advantages in more severely injured grafts.
The benefits of NEVKP have also been previously investi-
gated by other groups. Blum et al compared non-oxHMP with 
NEVKP for the preservation of DCD porcine kidney grafts.26 
After 45 min of WI and 5 h of SCS, grafts were perfused for 
8 h, and then graft function was assessed using a reperfusion 
model. Oxygen consumption, urine production, creatinine 
clearance, fractional excretion of sodium, proteinuria, and 
LDH and aspartate aminotransferase release into the perfu-
sate did not differ between groups. The differences in kidney 
function between groups might have not become apparent 
during reperfusion because of the limited time of assessment. 
In our study, because of the transplantation model, we were 
able to observe the function for several days and this might 
have made the differences between groups more obvious.
The Nicholson group has also compared NEVKP and 
HMP for the preservation of kidney grafts. In one study, after 
8 min of warm ischemia and 2 h of SCS, grafts were perfused 
for 16 h with either NEVKP or non-oxHMP and then an ex 
vivo reperfusion model was used for graft assessment.27 Renal 
function was similar in the 2 groups, but NEVKP preserved 
kidneys could concentrate creatinine and conserve sodium 
better. Graft assessment was limited to a few hours of reperfu-
sion, which makes function assessment more difficult. These 
results support our findings regarding the improved kidney 
function in NEVKP perfused grafts compared with HMP per-
fused grafts.
To our knowledge, only 1 other study compared NEVKP 
and HMP with or without oxygen in an in vivo model.28 Using 
a rodent model, grafts were exposed to 30 min of WI, 4 of SCS, 
1 h of either end-ischemic NEVKP or oxHMP or nitrogenated 
HMP and then transplanted. Grafts perfused with end-ischemic 
oxHMP performed better than the other groups with better 
survival rates, lower peak SCr, and less reactive oxygen species 
release. These results are different to our findings; however, fol-
lowing several hours of SCS, the limited perfusion of 1 h might 
have not been enough to unfold the benefits of NEVKP.
We also found that during NEVKP, less ApoExo vesicles 
are present in the perfusate, compared with the cold per-
fused groups. Recent findings have suggested that in injured 
endothelial cells, caspase-3 activation promotes the release of 
extracellular vesicles, including ApoExo, which enhance the 
recruitment of inflammatory cells and favor the production of 
antibodies, which aggravate vascular inflammation.29,30 Also, 
using a model of acute kidney injury in mouse, Dieude et al 
found that vascular injury increases proteasome caspase-like 
activity in exosome-like vesicles preparations.30 Reduced lev-
els of ApoExo vesicles during NEVKP are in line with our 
other findings and these results support our conclusion that 
NEVKP preservation is more protective compared with the 
cold preservation techniques.
NEVKP maintains metabolism active instead of slowing it 
down by cooling and allows for graft assessment and possi-
bly graft modification and repair. However, warm perfusion is 
technically and logistically challenging, involving higher costs 
and more trained personnel. One main advantage of HMP 
is its simplicity and the fact that it can be performed during 
transportation. Because of the low temperature, both graft 
assessment and treatment are limited.
Our model involved healthy young pigs without any underly-
ing kidney disease and a moderate kidney injury (30 min WI). It 
is possible that non-oxHMP and oxHMP offer benefits in older 
grafts or kidneys with underlying changes, for example due to 
hypertension or diabetes. Also, compared with SCS, HMP with 
and without oxygen might improve preservation injury.
One of the main strengths of our study is that kidney injury 
and function were observed in an in vivo model. Graft injury 
occurs not only during the ischemia period but is a complex 
process that also continues after reperfusion. Therefore, a 
transplantation survival model is best suited to fully appre-
hend the complexity of this process.
We acknowledge that our study has several limitations. The 
small number of animals per group might not allow for signif-
icant results to become obvious. Also, the allotransplantation 
model does not allow the possible immunological effects of the 
ex vivo preservation methods. Animals were only followed for 
8 d, which does not allow us to assess long-term graft func-
tion. The lack of histologic differences may be because of the 
late time-point at which the biopsy specimens were obtained, 
considering that by day 8 the kidney function was almost nor-
mal in all groups. It is possible that differences between the 
groups may exist at earlier time points, and these could poten-
tially have long-term effects. Also, the lack of prepreservation 
FIGURE 6. Urinary NGAL. NGAL measured in the urine was 
normalized to urinary creatinine concentration. Urinary NGAL was 
significantly lower in the NEVKP group vs the cold perfused groups 
(P = 0.01). * indicates significance between NEVKP and the other 2 
groups (n = 5 in each group). NEVKP, normothermic ex vivo kidney 
perfusion; NGAL, neutrophil gelatinase-associated lipocalin; non-
oxHMP, nonoxygenated hypothermic machine perfusion; oxHMP, 
oxygenated hypothermic ex vivo machine perfusion.
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graft injury and the good condition of the recipient might have 
resulted in a much sooner recovery of graft function, overstat-
ing the benefits of the ex vivo preservation techniques. Young 
pigs have the capacity to regenerate well after ischemic injury. 
The presence of only 1 kidney at termination of the experi-
ment might have resulted in a higher glomerular filtration rate 
of the transplanted kidney when compared with baseline. It is 
possible that the reported kidney function 8 d after transplan-
tation overestimates the actual kidney function.
Our study used 2 different devices for the preservation of 
the grafts. Because non-oxHMP is already well established 
in clinical trials, we choose to use a commercially available 
device for this group. Because in our country, there is no com-
mercial device available for oxHMP, we adapted our NEVKP 
system to perform oxHMP. To validate our oxHMP system, 
we initially performed several experiments comparing graft 
function in kidneys perfused with non-oxHMP with the 
LifePort System and with our device. The results were similar 
in both groups; however, because of space limitations, these 
data were not included in the current article.
Furthermore, the technical challenges of warm perfusion in 
the human setting should not be underestimated. Currently, 
there is no portable perfusion device available for NEVKP. 
Therefore, warm perfusion for the entire preservation period, 
as used in this study, is currently impractical in the human 
setting. It is possible that the optimal future preservation tech-
nique will include a cold perfused technique, with or without 
FIGURE 8. ApoExo perfusate levels. Levels of ApoExo in the 
perfusate at 1 h of perfusion (n = 5 in each group). Apoexo levels were 
lower in the NEVKP group vs the cold perfused groups. Significance 
was reached only between the NEVKP and oxHMP group (P = 0.02). 
*  indicates significance between NEVKP and the oxHMP group. 
ApoExo, apoptotic exosome;  NEVKP, normothermic ex vivo kidney 
perfusion; oxHMP, oxygenated hypothermic ex vivo machine perfusion; 
non-oxHMP, nonoxygenated hypothermic machine perfusion.
FIGURE 7. Histopathologic changes among the 3 experimental groups. (A) Graphical representation of tubular injury score comparing NEVKP, non-
oxHMP, and oxHMP groups, respectively, showing slightly greater injury (although not statistically significant) in the non-oxHMP group (n = 5 in each 
group). (B) PAS stained representative histology images from NEVKP, non-oxHMP, and oxHMP groups. NEVKP, normothermic ex vivo kidney perfusion; 
non-oxHMP, nonoxygenated hypothermic machine perfusion; oxHMP, oxygenated hypothermic ex vivo machine perfusion; PAS, periodic acid-Schiff.
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oxygen, followed by warm perfusion after arrival of the graft 
at the transplant center.
In summary, this study demonstrated superior initial graft 
function with prolonged NEVKP when compared with HMP 
with or without oxygen in a pig kidney DCD transplant 
model. No differences were found between HMP with and 
without oxygen. Faster recovery with NEVKP could possibly 
result in better and higher long-term graft survival. Moreover, 
during NEVKP graft viability could be assessed in real-time. 
Using NEVKP in a clinical setting could result in increased 
graft utilization. Future studies should aim to confirm our 
results and augment the usage of NEVKP in a clinical setting.
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